RyCarma Therapeutics, Inc., a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and skeletal muscle diseases, has appointed Elizabeth Tarka, M.D., ...

Researchers have found in a new study that oral anticoagulants OAC-naive patients experienced a smaller increase in stroke or ...

The Antikythera mechanism is one of the most mysterious and fascinating ancient inventions from the ancient world. Largely a mystery until the last few decades, the device has fascinated ...

EU countries have agreed on a market correction mechanism which will limit episodes of extraordinarily high gas prices in the EU and thus reduce the impact of price hikes on citizens and the economy.

memory update mechanisms are not at work. It is worth noting that correlations between TCAQ scores and fear responses in all three groups were not significant in the late phase of acquisition or the ...

These include: apixaban rivaroxaban edoxaban dabigatran injectable anticoagulants, also known as low molecular weight heparins. The most common side effects of all anticoagulants are bleeding and ...

The US Food and Drug Administration (FDA) has approved the first generics of Xarelto (rivaroxaban), a cardio vascular drug developed by Germany’s Bayer (BAYN: DE) and marketed in the USA by Johnson & ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

In preclinical models, researchers identified a key molecular mechanism by which stress and obesity trigger changes in pancreatic cells that may lead to cancer. Specifically, stress-related ...